U.S. approved the RSVpreF vaccine for adults 60 years and older in 2023, recommending it only based on individual’s decisions ...

Regulators say, however, the benefits of vaccination with Abrysvo and Arexvy in preventing respiratory syncytial virus ...

Predictions for this year from Perry Cohen, Pharm.D., CEO of the TPG Family of Companies and Managed Healthcare Executive ...

Anna Podolanczuk, M.D., M.S., discusses how biomarker testing plays a role in diagnosing idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), helping to distinguish these ...

Deramiocel is a cell therapy that has healing effects in muscle cells. If approved, deramiocel would be a once-quarterly ...

By narrowing their research to overweight and obese individuals, Roswell Park researchers found that metformin might offer ...

Regenerative medicine focuses on repairing damaged skin and bringing back melanocytes, the cells that give skin its color.

Conventional drug development typically zeroes in on individual proteins or signaling pathways. By focusing on the ...

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.

A systematic review and meta-analysis found some supporting evidence for transdermal anti-inflammatory patches, but the ...

Conventional drug development typically zeroes in on individual proteins or signaling pathways. By focusing on the ...

Opdivo Qvantig is the first subcutaneously administered PD-1 inhibitor approved by the FDA. It is expected to be available in ...